Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2026)

Charles River Laboratories International (CRL) posted Other Non-Current Assets of $587.6 million for Q2 2026, down 28.88% on a QoQ basis from $826.2 million in Q1 2026, and up 98.19% year-over-year from $296.5 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Other Non-Current Assets for 18 years, with the latest figure at $587.6 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 98.19% year-over-year to $587.6 million in Q2 2026; TTM through Jun 2026 was $587.6 million, a 98.19% increase from a year earlier, with the FY2025 full-year figure at $293.2 million, up 5.37% from the prior year.
  • Other Non-Current Assets was $587.6 million for Q2 2026 at Charles River Laboratories International, down from $826.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $826.2 million in Q1 2026, with the low at $148.3 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $329.0 million, with a median of $298.8 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets tumbled 64.31% in 2023, then surged 180.91% in 2026.
  • Over 5 years, Other Non-Current Assets stood at $148.3 million in 2022, then surged by 108.65% to $309.4 million in 2023, then slipped by 10.07% to $278.2 million in 2024, then grew by 5.37% to $293.2 million in 2025, then soared by 100.4% to $587.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $587.6 million (Q2 2026), $826.2 million (Q1 2026), and $293.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 25.20 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 117.41 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 587.56 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 91.80 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 1.28 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 87.48 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 201,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 91,801.74
10 VivoSim Labs 1.37 Mn 1.37 Mn - 143,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 587.56 Mn
Mar 28, 2026 826.17 Mn
Dec 27, 2025 293.19 Mn
Sep 27, 2025 290.89 Mn
Jun 28, 2025 296.46 Mn
Mar 29, 2025 294.10 Mn
Dec 28, 2024 278.23 Mn
Sep 28, 2024 307.01 Mn
Jun 29, 2024 301.18 Mn
Mar 30, 2024 303.15 Mn
Dec 30, 2023 309.38 Mn
Sep 30, 2023 154.88 Mn
Jul 1, 2023 155.47 Mn
Apr 1, 2023 153.99 Mn
Dec 31, 2022 148.28 Mn
Sep 24, 2022 429.69 Mn
Jun 25, 2022 435.64 Mn
Mar 26, 2022 356.65 Mn
Dec 25, 2021 151.54 Mn
Sep 25, 2021 341.45 Mn